lopinavir
别名 | ABT-378, ABT378, Kaletra® (LPV+RTV), Aluviran®, A-157378-0, A-1573780 |
---|---|
Compound Class | Synthetic organic |
变动原因 |
Lopinavir is an antiretroviral protease inhibitor. It has subsequently been discovered to exhibit antiviral activity against human papilloma virus (HPV), and to inhibit MERS-CoV replication in vitro |
Related Product | Lopinavir |
Summary
是否批准为药物? | (FDA (2000), EMA (2001)) |
---|---|
IUPAC Name | (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide |
别名 | ABT-378, ABT378, Kaletra® (LPV+RTV), Aluviran®, A-157378-0, A-1573780 |
数据库链接
生物活性
生物活性评价 |
Inhibits HIV1 protease with Ki 0.0013 nM in vitro |
---|
临床资料
Summary of Clinical Use |
Lopinavir is used in combination with |
---|---|
作用机制与药效学效应 |
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants |
参考文献
1. de Wilde AH, Jochmans D, Posthuma CC, Zevenhoven-Dobbe JC, van Nieuwkoop S, Bestebroer TM, van den Hoogen BG, Neyts J, Snijder EJ. (2014) Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.. Antimicrob Agents Chemother, 58 (8): (4875-84). [PMID:24841269] |
2. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M et al.. (2020) A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.. N Engl J Med, 382 (19): (1787-1799). [PMID:32187464] |
3. Sham HL, Betebenner DA, Herrin T, Kumar G, Saldivar A, Vasavanonda S, Molla A, Kempf DJ, Plattner JJ, Norbeck DW. (2001) Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir).. Bioorg Med Chem Lett, 11 (11): (1351-3). [PMID:11378352] |
4. B?hm R, Bulin C, Waetzig V, Cascorbi I, Klein HJ, Herdegen T. (2021) Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections.. Br J Clin Pharmacol, 71 (13): (1755-70). [PMID:33871897] |
结构
Canonical SMILES | O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@@H](N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C |
---|---|
Isomeric SMILES | O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@@H](N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C |
InChI | InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 |
InChI key | KJHKTHWMRKYKJE-SUGCFTRWSA-N |